The announcement of capital expenditures for FY24 by Danimer Scientific provides insight into the company's planned investments and financial management. While this indicates ongoing investments in its operations, the impact on the stock price in the short term is likely neutral. Investors may view this as a sign of stability or growth, but the exact effect will depend on broader market perceptions and the context of these expenditures.